Efficacy of ranolazine in preventing atrial fibrillation following cardiac surgery: Results from a meta-analysis

BACKGROUND: Atrial fibrillation (AF) is a common complication after cardiac surgery. Ranolazine is a Food and Drug Administration approved anti-ischemic drug, which also has anti-arrhythmic properties. Recent studies have demonstrated the benefit of ranolazine in preventing post-operative AF (POAF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Chintan, Upadhyay, Ankit, Solanki, Kinjal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459427/
https://www.ncbi.nlm.nih.gov/pubmed/28607609
http://dx.doi.org/10.1016/j.joa.2016.10.563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459427/
https://www.ncbi.nlm.nih.gov/pubmed/28607609
http://dx.doi.org/10.1016/j.joa.2016.10.563

Ejemplares similares